DGAP-Adhoc: UMS AG Revises Earnings Projections

 | Source: EQS Group AG EQS Group AG 

UMS United Medical Systems International AG  / Key word(s): Quarter
Results/Profit Warning 

05.08.2011 16:23

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

UMS AG Revises Earnings Projections

  - Cost of integrating acquired companies adversely affects earnings 

  - Radiology fleet will not operate at full capacity until August 2011

  - Weak U.S. dollar results in lower earnings in euros

  - Earnings per share of EUR0.45 to EUR0.55 expected for 2011

Hamburg, August 5, 2011. The Management Board of UMS United Medical Systems
International AG, Hamburg (ISIN DE 0005493654 /WKN 549365), believes that
the outlook for the current fiscal year will be adversely affected by two
one-time factors and by the weak U.S. dollar.

From today's vantage point, the Company now expects earnings per share of
EUR0.45 to EUR0.55 for fiscal year 2011. Previously UMS AG had expected
earnings of between EUR0.60 and EUR0.70 per share. Preliminary figures show
earnings for the first half of 2011 in the amount of EUR0.24 per share, as
compared to EUR0.30 per share in the first half of 2010. Revenues in the
first half of 2011 amounted to EUR18.6 million, following EUR19.3 million
in the same period last year. EBIT stands at EUR5.6 million according to
preliminary figures, following EUR6.2 million in the previous year.
Adjusted for exchange rate effects, prior-year revenue came to EUR18.1
million and EBIT amounted to EUR5.8 million. Earnings per share in the
first half of 2010 were EUR0.28 after currency effects.

The main reason for the revision is the cost of integrating companies
rising above expectations, especially for the competitor Mobile Biopsy,
which was acquired in April 2011. Another factor is the delay in signing up
customers for the fleet of radiology equipment. Many of these deals were
expected to close in the first half of 2011. Therefore, use of this
equipment is not likely to reach the level planned until August of the
current fiscal year.

In addition, the weakness of the U.S. dollar reduces the earnings shown in
euros. The Company does 98% of its business in the U.S. dollar zone.

These integration costs and the delays in signing up customers for the
fleet of radiology equipment will no longer have any influence on earnings
in fiscal year 2012.

UMS AG expects to maintain its dividend policy for 2011, as long as the US
dollar against the Euro does not weaken substantially from its current
trading range.




Contact
Wiebke Budwasch, Tel: (040) 500 177-00, Fax: (040) 500 177-77, E-mail:
investor@umsag.com




05.08.2011 DGAP's Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      UMS United Medical Systems International AG
              Borsteler Chaussee 53
              22453 Hamburg
              Germany
Phone:        +49 (0)40 - 500 177 - 00
Fax:          +49 (0)40 - 500 177 - 77
E-mail:       investor@umsag.com
Internet:     www.umsag.com
ISIN:         DE0005493654
WKN:          549365
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------
GlobeNewswire